1800 202 8726
Molecular & Genomic Testing

Is There Enough Tissue — for Molecular Testing?

Insufficient tissue is the commonest reason molecular testing fails — and it is usually preventable. The type of biopsy done first, and whether the right amount was sent to the right laboratory, determines whether your results come back at all.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • The biopsy type is usually the cause — FNAC collects individual cells. Core needle biopsy removes a cylinder of tissue. Only tissue reliably gives enough DNA for most molecular panels.
  • The wax block may still have more — The paraffin block stored after your original biopsy sometimes holds untouched tissue that can be re-sectioned for testing without a new procedure.
  • Blood can sometimes stand in for tissue — Liquid biopsy detects tumour DNA in the bloodstream. Whether it is appropriate for your cancer type depends on your oncologist's assessment.
  • A repeat biopsy is often brief — Most core biopsies are done as a day procedure. Whether one is safe depends on where the tumour sits and what has changed since the first sample.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Insufficient tissue is the commonest reason molecular testing fails. Whether a repeat biopsy is needed depends on whether the existing block holds more material, whether a blood-based liquid biopsy suits your cancer type, or whether the lesion can be re-sampled safely. Your oncologist and pathologist will assess all three options before deciding.

Why does the type of biopsy affect whether molecular testing works?

Molecular testing reads the DNA inside tumour cells. To do that reliably, the laboratory needs enough tumour cells and enough intact DNA — and the type of biopsy done first determines whether that threshold is met.

FNAC uses a thin needle to draw individual cells into a syringe. It is quick, widely available, and excellent for confirming whether cancer is present. It was not designed for molecular work. The cells collected are few, the DNA is often fragmented, and there is no preserved tissue architecture for the pathologist to work from.

A core needle biopsy removes a small cylinder of tissue. That cylinder preserves the arrangement of cells, contains far more material, and yields the DNA quality most molecular panels require. When molecular testing is planned from the start, NCCN and ASCO guidance consistently recommends core biopsy as the preferred procedure.

What should I ask when the sample was not big enough?

  • Ask whether the paraffin block from the original biopsy contains uncut tissue that can be re-sectioned
  • Ask whether a liquid biopsy from blood is appropriate for your cancer type and stage
  • Ask which tests matter most for your treatment decision right now — your oncologist can prioritise
  • Ask whether the original tumour site is still safely accessible for a repeat core biopsy
  • Ask for a specific timeline, and whether treatment planning can begin in parallel while the sample question is resolved

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What do these words on your report actually mean?

FNAC (Fine Needle Aspiration Cytology)
A thin needle draws individual cells from the tumour. Quick and minimally invasive, but yields little material and no tissue architecture. Often insufficient for comprehensive molecular panels.
Core needle biopsy
A slightly wider needle removes a small cylinder of tissue. Preserves cell structure, provides more DNA, and is the preferred method when molecular testing is anticipated.
FFPE block
The formalin-fixed, paraffin-embedded wax block that stores your biopsy tissue in the pathology lab. It can often be re-sectioned — cut into further thin slices — to yield more material for testing.
Tumour cellularity
The proportion of the sample that is actually tumour cells, rather than surrounding normal tissue or blood. Low cellularity is one of the two main reasons a sample fails to produce a molecular result.
Liquid biopsy
A blood test that detects DNA fragments shed by tumour cells into the bloodstream. Used when tissue is unavailable or insufficient; sensitivity varies by cancer type and stage.
Tissue triaging
Planning upfront which tests to run from a limited sample and in what order, before any cuts are made. Done by the pathologist and oncologist together to avoid wasting irreplaceable material.

Did you know?

FNAC remains the commonest first biopsy in India because it is inexpensive and available at most hospitals. But it was designed for diagnosis, not for molecular characterisation.

If a core biopsy is possible at your cancer site, asking for one at the outset avoids the insufficient-tissue problem entirely — and costs less time than resolving it later.

Source: NCCN Guidelines: Principles of Molecular Pathology Testing

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Does insufficient tissue always mean I need a repeat biopsy?

Not always. The first step is asking whether the original wax block contains more uncut tissue — many blocks hold enough for additional sections. If the block is exhausted, the next question is whether a liquid biopsy from blood is appropriate for your cancer type. A repeat biopsy is considered only when both those options are ruled out. Your pathologist and oncologist will check in that order before asking you to undergo another procedure.

Can a blood test replace tissue for molecular testing?

Liquid biopsy detects tumour DNA in the bloodstream and can provide some of the same information as tissue testing, but it is not equivalent for all cancers or all tests. Sensitivity varies by cancer type, stage, and which mutations are being looked for. For some cancers it is a validated alternative when tissue is unavailable. For others, tissue remains necessary. Your oncologist will tell you whether it is an option in your situation — do not order it without that guidance, because a negative result from a liquid biopsy does not always mean a mutation is absent.

Why was FNAC done first if it might not give enough tissue?

FNAC is faster, cheaper, and less uncomfortable than a core biopsy, and it is usually enough to confirm that cancer is present — which is often the most urgent question. Molecular testing comes later, once the cancer type is established. If there is any possibility that molecular testing will be needed, ask your team at the time of the first biopsy whether a core sample can be taken at the same sitting. This prevents the problem before it starts.

How long will a repeat biopsy delay my treatment?

Most core biopsies are done as day procedures, and the procedure itself rarely takes more than an hour. The delay comes from arranging the procedure, processing the tissue, and running the molecular tests — a timeline your oncologist can give you in specific terms. Ask also whether any part of treatment planning can begin before the results are back. In many situations the team can make preliminary decisions while molecular results are awaited, shortening the effective delay.

Can the pathologist use a biopsy block from years ago?

Sometimes. Paraffin blocks preserve tissue for years and can be re-sectioned for molecular testing well after the original procedure. The main limitations are DNA quality, which can degrade over time, and how many cuts have already been made from the block. Your oncologist will ask the pathology lab to assess the block before ordering tests from it. If the block is from another hospital, it can usually be retrieved — ask your team to arrange that rather than assuming it is unavailable.

Who decides whether a sample is adequate for testing?

The pathologist who receives the sample makes the first assessment of whether there are enough tumour cells. If a molecular panel is then ordered, the molecular laboratory also assesses adequacy before processing begins. When a sample fails, the report says why — whether there were too few cells, too little DNA, or poor DNA quality — and that specific reason guides what happens next. Ask to see the report so you understand exactly what the limitation was.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation